Invest in

HIV Treatment

20.0%
4.9%
0.3%

The companies in this Motif sell FDA approved prescription drugs used for the treatment of HIV. The Motif is weighted by the companies HIV sales and the likelihood that the drug the company sells will be used in an HIV regimen See more
20.0%
4.9%
0.3%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
HIV Treatment Benchmark
Open a Motif account to view and trade this basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
24.9% Atripla, Reyataz, Sustiva, Evotaz 9.4%
24.9% Bristol-Myers Squibb Company BMY 9.4%
19.8% Parent Companies of Viiv Healthcare 10.9%
10.8% 8xxxxx 8xxx 8xx 88.8%
9.0% 8xxxxxxxxxxxxxx 8xx 8xx 88.8%
17.9% Biotechnology 14.9%
17.9% Gilead Sciences Inc. GILD 14.9%
15.6% Kaletra,Norvir 71.2%
15.6% AbbVie Inc. ABBV 71.2%
10.7% Edurant, Prezista, Intelence 31.2%
10.7% 8xxxxxx 8 8xxxxxx 8xx 88.8%
6.4% Isentress 4.1%
6.4% 8xxxx 8 8xxxxxx 8xxx 8xxxx 8xx 88.8%
4.7% Generic Manufacturers 0.5%
2.8% 8xxxxxxx 8xx 8xx 88.8%
1.0% 8xxxx 8xxx 8xx 88.8%
0.9% 8xxxxxxx 8x 8xx 88.8%

Quotes delayed 15 mins. Currently Jan 18, 2018 4:30:34 PM. Fields are marked with -- when data is unavailable.